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Abstract
Background: In order to enable replication of effective complex interventions, systematic reviews need to provide
evidence about their critical features and clear procedural details for their implementation. Currently, few systematic
reviews provide sufficient guidance of this sort.
Methods: Through a worked example, this paper reports on a methodological approach, Intervention Component
Analysis (ICA), specifically developed to bridge the gap between evidence of effectiveness and practical
implementation of interventions. By (a) using an inductive approach to explore the nature of intervention features
and (b) making use of trialists’ informally reported experience-based evidence, the approach is designed to
overcome the deficiencies of poor reporting which often hinders knowledge translation work whilst also avoiding
the need to invest significant amounts of time and resources in following up details with authors.
Results: A key strength of the approach is its ability to reveal hidden or overlooked intervention features and
barriers and facilitators only identified in practical application of interventions. It is thus especially useful where
hypothesised mechanisms in an existing programme theory have failed. A further benefit of the approach is its
ability to identify potentially new configurations of components that have not yet been evaluated.
Conclusions: ICA is a formal and rigorous yet relatively streamlined approach to identify key intervention content
and implementation processes. ICA addresses a critical need for knowledge translation around complex
interventions to support policy decisions and evidence implementation.
Keywords: Systematic reviews, Evidence synthesis, Complex interventions, Knowledge translation, Paediatrics,
Medication error, Electronic prescribing
Background
Enhancing the utility of evidence for policy decisions
Whilst the body of systematic reviews examining the ef-
fectiveness of interventions is burgeoning [1], currently
few systematic reviews provide sufficient guidance to en-
able practical application of the evidence synthesised [2].
To enable replication of effective complex health service
interventions, systematic reviews need to provide evi-
dence about the critical features of interventions and
clear procedural details for their implementation.
The current lack of such information has been attrib-
uted to a number of factors. First, some argue that to
date, there has been a lack of awareness among system-
atic reviewers of the information needs of users of sys-
tematic reviews [2]. A second contributor to the
problem is the often substandard reporting of interven-
tion details in primary studies [3, 4]. A third reason is
the complexity of many non-pharmacological interven-
tions [5, 6] which in turn undermines the ability of
established statistical approaches to distinguish the im-
pact of different intervention features on outcomes. This
paper reports on a methodological approach, Interven-
tion Component Analysis (ICA), specifically developed
to overcome these challenges and to bridge the gap be-
tween evidence of effectiveness and practical implemen-
tation of interventions.* Correspondence: k.sutcliffe@ioe.ac.uk
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Understanding the needs of review users
At the EPPI-Centre, we have been sensitised to the in-
formation needs of decision-makers through our long-
standing programme of work with the Department of
Health, England, to undertake systematic reviews to in-
form policy. One feature that distinguishes many of
these reviews to inform policy development (and imple-
mentation) is that they tend to be broader than system-
atic reviews carried out to inform decisions in clinical
situations. Rather than beginning with the standard
PICO framework, which defines the Population, Inter-
vention, Comparator and Outcome of interest, the pol-
icymaker often begins with an Outcome (or outcomes)
of interest and seeks to identify a range of approaches
which might improve this/those outcome/s (such as
‘healthy eating’, ‘physical activity’, etc.). Populations tend
to be fairly broad: ‘adults’, ‘children’ or ‘young people’, ra-
ther than very narrow age ranges or those with specific
pre-existing conditions. Such reviews are less concerned
with identifying a single pooled effect size estimate, as
may be the case in clinical reviews, than with identifying
intervention approaches which may be useful in particu-
lar situations or with particular population (sub)groups.
Thus, as well as addressing questions of effectiveness
(‘what works?’), reviews to inform policy also need to an-
swer the question ‘what works, for whom, in what situ-
ation?’. In addition, reviews for policy also utilise a much
wider range of evidence than early clinical systematic re-
views with their exclusive focus upon randomised con-
trolled trials (RCTs) [7, 8]. Some policy questions go
beyond effectiveness (e.g. ‘is there a problem?’, ‘what can
we do about..?’, ‘what are people’s experiences of..?’, and
‘can a particular intervention be implemented in this
context?’); thus, different types of research are required
in addition to trials, including epidemiological research
(such as surveys and cohort studies) and qualitative
studies. The EPPI-Centre works to develop systematic
review methods to accommodate the broad range of
policy-relevant questions and the concomitant range of
research. The ICA approach described in this paper is
one such development.
Addressing the problem of poor quality intervention
descriptions
Despite the fact that the 2010 Consolidated Standards of
Reporting Trials (CONSORT) statement recommends
that authors should report interventions with ‘sufficient
details to allow replication’ [9], evidence indicates that
substandard reporting of intervention details is wide-
spread [3, 4]. Thus, even if reviewers are sufficiently sensi-
tised to decision-makers’ implementation needs, accessing
sufficient information from primary studies will remain a
significant challenge.
To remedy this situation, the ‘TIDieR’ Checklist has
been designed to supplement the CONSORT statement
with a view to improving the reporting of interventions;
the authors are also mindful of the implications for sys-
tematic reviews and review users [10]. Nevertheless,
given the information needs of review users, and pend-
ing the impact of efforts such as TIDieR to ensure im-
provements in reporting, reviewers need to find ways to
overcome the current problem of ‘remarkably poor’
reporting of intervention details [10]. One suggested ap-
proach is to contact trial authors for additional details
[3, 11]. However, this approach has been found to re-
quire ‘considerable extra work’ compared to a standard
review, which may not always be feasible [2]. In some
cases, it has also produced limited results: in their study
of RCTs of non-pharmaceutical interventions, Hoffmann
and colleagues found that only 39 % of published trials
provided adequate description of interventions, and the
rate of adequate information increased to just 59 % fol-
lowing attempts to contact authors [3].
The challenge of reporting complex interventions
Interventions that are carried out in a social context are
prone to poor reporting, due to their complexity. The
term ‘complex intervention’ is in common use, and there
is the Medical Research Council guidance on how to de-
velop and evaluate such interventions [12]. This guid-
ance defines complexity in terms of the following:
 Number of interactions between components
 Number and difficulty of behaviours required by
those delivering or receiving the intervention
 Number of groups or organisational levels targeted
by the intervention
 Number and variability of outcomes
 Degree of flexibility or tailoring of the intervention
permitted (p. 7)
However, whilst it may be difficult to identify the ‘ac-
tive ingredients’ of an intervention with the above char-
acteristics, some of these issues may be considered as
merely ‘complicated’; in an alternative conceptualisation,
complex interventions are characterised by ‘recursive
causality (with reinforcing loops), disproportionate rela-
tionships (where at critical levels, a small change can
make a big difference—a ‘tipping point’) and emergent
outcomes’ [13].
The distinction between an intervention and the con-
text in which it is implemented is often less clear in the
case of complex interventions meaning that mechanisms
of action or causal pathways are often obscured [6].
Wells and colleagues argue that ‘There is potential for
the cause to be: the intervention itself, elements of the
healthcare context within which the intervention is
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being delivered, elements of the research process that
are introduced to that setting (for example, presence of
researchers and their operations), or a combination of
all three’ [6]. Multiple potential influences will necessar-
ily increase the challenge of providing an accurate and
comprehensive description in trial reports. Moreover, it
is posited that researchers may be reticent to recognise
or report the influence of contextual factors on the de-
livery or impact of interventions since an inherent aim
of randomised controlled trials is to control and stand-
ardise the interventions under study [6].
The challenge of identifying critical components in
complex interventions
Statistical approaches for exploring variation in out-
comes have a long history of use in systematic reviews,
including methods such as meta-regression, subgroup
analysis, network meta-analysis and various other mod-
erator analyses [14, 15]. These statistical methods, which
partition and attempt to explain between-study variance
in different ways, are a powerful way of identifying
which intervention characteristics might be necessary
and/or sufficient, individually or in combination, to
bring about a given outcome. Unfortunately, they all
share one significant weakness in terms of their utility:
they depend on intervention replication in order to op-
erate effectively. In situations in which each intervention
in a review may differ from another (in sometimes subtle
ways), they have less traction; and in evaluations of so-
cial interventions, there are very few genuine replica-
tions. This means that systematic review datasets often
lack the necessary numbers of studies that might allow
them to explore meaningful numbers of mediators and
moderators of intervention effect. They are therefore
often unable to identify which intervention characteris-
tics should be selected by decision-makers in different
situations. When faced with unexplainable heterogeneity,
most reviewers resort to a ‘narrative’ synthesis, in which
the results of studies are compared to one another the-
matically [16].
Moreover, when considered alongside the brief discus-
sion earlier about the nature of complicated and complex
interventions, and the need to identify ‘active ingredients’
for decision-makers, correlation-based methods have
some serious weaknesses, which limit their suitability for
use in these situations; most importantly, typically they do
not allow for the possibility of multiple causal configura-
tions. Correlation tests are symmetric in nature, which
means that when the strength of a given relationship is
tested, part of the test requires the absence of a non-
relationship—which may not make sense conceptually,
and is certainly a problem in terms of detecting multiple
causal pathways. For example, in an analysis which is
examining whether training intervention providers results
in better outcomes, a correlational analysis will require
that training intervention providers is associated with
good outcomes and that the absence of training providers
is associated with poorer outcomes. However, if there are
multiple routes through to effectiveness, it may be that
some (or all) of the interventions where training did not
occur had good reasons for this (e.g. they had recruited
more experienced providers) but this would not be picked
up in the analysis, and the importance of training in the
interventions which did train providers would be lost.
There are, of course, refinements to simple correlational
tests which test for interactions between variables (e.g.
training and/or experience of providers), but they tend to
require more data (i.e. more replications of sufficiently
similar interventions) to operate.
As such, the ability of conventional statistical ap-
proaches to detect key intervention features is question-
able in the arena of complex interventions. However, if
policymakers and practitioners are to base their deci-
sions on the findings of systematic reviews, they still re-
quire information to guide the selection and prescription
of a specific approach. Whilst it may not be possible to
test hypotheses reliably using the statistical approaches
described above, the development and articulation of
hypotheses about critical intervention features may
nevertheless provide further insight for decision-makers.
Challenges to developing and articulating theories of
intervention mechanisms
Developing theory or presenting existing theoretical
models as part of a review has been recommended as
one approach to address the ‘missing link’ with regard to
translation of evidence for decision-makers [2, 17]. One
of the tools which is gaining increasing popularity is the
use of programme theory or logic models to detail the
causal pathway(s) through which an intervention is
intended to have its effect [18]. Often depicted in dia-
grammatic form, logic models can illustrate connections
between outcomes and what influences them, describe
mediators and moderators and specify intermediate out-
comes and possible harms [19].
However, whilst articulation of the theoretical basis of
interventions can help with knowledge translation, there
are a number of potential weaknesses to this approach
[20]. First, the programme theories may not correctly
identify and understand all relevant mechanisms; evi-
dence suggests that important mechanisms are often
missed and that identified mechanisms sometimes have
‘surprising side effects’ [20]. Second, the programme the-
ory is only helpful if the intervention is implemented
correctly, such that the theoretical mechanisms remain
intact.
Moreover, whilst theory can help to explain how or
why a particular intervention or component might work,
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opportunities to build on the experience of actually
implementing and delivering specific interventions are
still missed if a priori theory is the sole focus of analysis.
Experiential knowledge can uncover potentially neglected
aspects of interventions which are actually important for
their effectiveness. As Penelope Hawe notes in her discus-
sion of improvement science, consideration of valuable
experiential knowledge comes ‘from the hands of practi-
tioners/implementers’ and that ‘failure to acknowledge
this may blind us to the very mechanisms we seek to
understand’ [21] Building on experience can be done by
integrating evidence on the effectiveness of complex
interventions with other types of research evidence
[22], for example, qualitative studies which explore
the views and experiences of intervention recipients
or providers [23, 24]. But, unless the experiential data
is drawn from process evaluations conducted along-
side effectiveness trials, we are not able to build on
lessons learned about key ingredients during the prac-
tical application of effective interventions and in par-
ticular in situations where the programme theory is
not supported by the evidence. Unfortunately, learn-
ing from practical application is often hampered by a
lack of high-quality process evaluations [25, 26].
The context in which Intervention Component Analysis
was developed
The ICA approach, described through a worked example
below, was developed in a review examining the effect-
iveness of interventions to reduce medication errors in
children. We focus here on one type of intervention ex-
amined in that review: paediatric electronic prescribing.
Often referred to as Computerised Prescription Order
Entry (CPOE), electronic prescribing involves entering
and processing prescription orders via computer, as op-
posed to traditional paper-based systems.
The review commissioners specifically requested an
exploration of implementation issues as part of the re-
view, and we were faced with many of the factors and
challenges described above. Electronic prescribing is a
complex intervention, owing to the potential for vari-
ance in the features of computer programmes as well as
the context within which CPOE is used. For CPOE, the
programme theory is well established: it is hypothesised
that medication errors are reduced as electronic pre-
scribing enables access to clinical decision support at the
point of care and ensures that orders are legible and
complete; yet, we found a large amount of variance in
outcomes among the included studies. We were also
hampered by a lack of detail about the nature of elec-
tronic prescribing; the quality of many intervention de-
scriptions was suboptimal, and very few trials conducted
process evaluations. Producing the review according to
the policy timetable precluded the time-consuming
options of seeking additional qualitative studies or con-
ducting multiple rounds of author survey.
The review, therefore, needed to adopt a novel ap-
proach to assist decision-makers in understanding the
critical components of paediatric electronic prescribing
packages.
What is Intervention Component Analysis and how does
it overcome the challenges of identifying critical
components of complex interventions?
In essence, the ICA approach aims to identify what an
effective intervention ‘looks like‘. It is suitable for situa-
tions where we have a group of similar intervention-
s—aiming to impact on the same outcome—but which
differ from one another in small ways, and we do not
know which are important in terms of impacting on the
outcome. However, it is particularly appropriate in situa-
tions where existing programme theory has been unable
to explain variance in outcomes and where there is sub-
optimal information about the interventions under scru-
tiny (i.e. low-quality intervention descriptions and a lack
of process evaluations). Two key approaches are employed
in the analysis of trial reports to overcome these chal-
lenges. First, qualitative data analysis techniques are
employed to develop an inductively derived understanding
of the nature of interventions; the inductive approach
aims to ensure meticulous analysis of intervention de-
scriptions and to facilitate comparison across the set of
studies. Second, to augment the understanding of the
intervention, informally reported evidence about the ex-
perience of developing and implementing the intervention
is captured from the discussion sections of trial reports.
See Table 1 for a summary of ICA.
Methods
The method involves two stages. The first seeks to iden-
tify how interventions differ from one another; the sec-
ond then seeks to identify which of these differences in
intervention characteristics appear(s) to be important.
The first stage, understanding differences between inter-
ventions, contained two distinct and parallel processes:
the ‘effectiveness synthesis’ carried out a standard ‘narra-
tive’ analysis which sought to identify any clinically sig-
nificant differences in the outcomes reported by the
evaluations; and in parallel to this, another team of re-
searchers carried out the first stage of the ICA—under-
standing the characteristics of included interventions in
detail.
The results of the two pieces of analysis—the success/
failure of individual studies, and the detailed classifica-
tions of individual study characteristics—were then com-
bined in the final stage of the ICA, which sought to
understand variation in outcomes through mapping
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them against the intervention characteristics. This ana-
lytical structure is summarised in Fig. 1.
Stage one: understanding how interventions differ from
one another
In the first stage, we gathered as much evidence as pos-
sible about the nature of the electronic prescribing inter-
vention in each trial. As described above, two approaches
were employed to mitigate the problem of suboptimal—-
sparse and inconsistent—information about the interven-
tions. First, qualitative data analysis techniques are used to
gather information about interventions: line-by-line cod-
ing to ensure that all available information was captured
and inductive coding to deal with inconsistencies in the
descriptions of intervention features [27]. Second, we
employed a broader view of ‘evidence’ than is typical for a
systematic review; we examined discussion sections of trial
reports to capture trialists’ reflections and accounts of the
experience of using the intervention. Although trialists’ ac-
counts cannot be considered research evidence, as formal
methods were not employed to collect or analyse this data,
the use of this informal evidence offers much needed
insight into the experience of using and delivering an
intervention.
We employed these approaches to gather evidence on
three dimensions of the intervention:
a) The features described as present in electronic
prescribing interventions
b) The strengths/weaknesses of individual intervention
features
c) The process of development and implementation
Capturing and coding intervention descriptions
With regard to a) capturing evidence on intervention
features, we detailed all available information about
intervention components as described by the authors.
There was a huge variation in the level of detail pro-
vided. To provide a crude example, some studies pro-
vided descriptions of several hundred words long and
provided illustrations, whilst others provided much
shorter descriptions; and indeed, one study simply
named the intervention as CPOE without providing any
description of its characteristics. However, line-by-line
coding ensured that we made use of every piece of avail-
able information. Inconsistency in the definition and de-
scription of features was common; for example,
‘structured order sets’, which allow a prescriber to select
with one click a complete order for commonly pre-
scribed medicines, were variously described as ‘order
sets’, ‘pre-constructed orders’ and ‘default prescriptions’.
Inductive thematic coding enabled us to identify and cat-
egorise these similar concepts such that we could ‘map’
the presence or absence of the range of described fea-
tures to assess how interventions differed from one
another.
Capturing informal evidence on the experience of
developing and using interventions
The inclusion of informal evidence enabled us to go be-
yond intervention descriptions and examine evidence in
the form of real-world experiences of electronic pre-
scribing systems. Few studies employed formal research
methods to examine process and implementation issues.
However, the vast majority of studies provided a wealth
of informal evidence via rich description by authors
about the perceived strengths and weaknesses of particu-
lar features as well as the experience of developing,
using and implementing electronic prescribing packages.
Such evidence included authors’ reporting of informal
feedback from users of the electronic prescribing sys-
tems (e.g. hospital doctors), authors’ observations of the
impact of electronic prescribing on working practices,
and authors’ conclusions regarding associations between
intervention features and the success (or otherwise) of
Table 1 Overview of the ICA approach
Aims to answer… ○ How do interventions differ from one another?
○ Which of these differences in characteristics appears to be important?
○ What would an ideal version of the intervention ‘look like’?
Assumes that… ○ Characteristics that are present in all/many effective interventions are worthy
of attention
○ Characteristics that may be present in one/small numbers of intervention(s)
may be less important
Addresses the challenge of poor quality intervention
descriptions by…
○ Using an inductive approach to explore the nature of intervention features
○ Making use of trialists’ informally reported experience-based evidence
Fig. 1 Structure and sequencing of analyses
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the intervention. We employed inductive thematic ana-
lysis to produce a narrative structure around the emer-
gent themes.
Stage two: which intervention characteristics appear to
explain differences in outcomes?
In the second stage, to identify which intervention fea-
tures appeared to be important for successful outcomes,
we used the mapped intervention features and the emer-
gent themes from the informal data to re-examine the
outcomes of the effectiveness synthesis. We sought to
identify whether the small number of studies with nega-
tive outcomes were qualitatively different to those with
positive outcomes.
Approaches for mitigating potential weaknesses of the
ICA approach
The effectiveness synthesis and ICA were conducted
consecutively. However, aside from the primary inves-
tigator, they were conducted by different research
teams. The independence of the research team con-
ducting the ICA minimised the potential pitfalls of
post hoc reasoning.
With regard to capturing evidence from intervention
descriptions, it must be recognised that without seeking
confirmation from authors about the absence of particu-
lar features, it remains unclear whether features that
were not described in trial reports were not present in
the intervention or whether they were simply overlooked
in the description. Confirmation from authors would
have increased confidence in the review’s conclusions.
However, given the level of informal scrutiny and reflec-
tion on the importance of components by authors of the
primary studies, it seems reasonable to assume that they
would have described and emphasised the features that
they considered to have had a discernible impact on
outcomes.
Although it provided vital insight into the electronic
systems under study, the informal evidence examined as
part of the ICA is, of course, at risk of being partial or
biased, since formal research methods designed to re-
duce inherent biases were not employed. We attempted
to mitigate this weakness in a number of ways. First, we
were explicit about the extent of such data contributing
to each theme and the consistency of opinion across the
studies. The process of checking that themes that
emerged from this data were corroborated by evidence
in the effectiveness synthesis in stage 2 of the ICA pro-
vided a second validity check. Lastly, following the com-
pletion of the analysis, we sought to identify if the
themes were corroborated by relevant research identified
during the course of the review which did not meet our
inclusion criteria, such as qualitative studies.
Results
Description of included studies
The review identified 20 trials of electronic prescribing in-
terventions evaluated in paediatric populations [28–47];
the findings showed it to be a largely successful interven-
tion for tackling medication error and other related out-
comes in this population although some studies revealed
the potential for negative consequences. Fifteen studies
examined the impact of electronic prescribing on paediat-
ric medication error (PME), of which nine found statisti-
cally significant reductions, a further four found reduced
PME although the findings were not statistically signifi-
cant, and two studies found small non-significant in-
creases in PME. Evidence also suggests that electronic
prescribing can reduce mortality rates and adverse drug
events (ADE) associated with errors. However, a small
number of studies (n = 3) suggested that it has the poten-
tial to increase harms for children [31, 37, 42]; most not-
ably, one study found a statistically significant increase in
mortality following the implementation of electronic pre-
scribing [30]. Full details of the included studies and re-
sults of the review can be found in the study report which
is available on-line [48].
Intervention features
The 20 studies all evaluated an intervention for clini-
cians which involved entering and processing prescrip-
tion orders via computer as opposed to handwritten
paper-based prescriptions. However, there was an array
of additional features which varied according to each in-
dividual package. The inductive coding process enabled
us to map these intervention features at a number of
levels. Inductively generated higher level descriptive
themes were used to group specific features according to
(a) the package type; (b) front-end decision support fea-
tures; and (c) back-end decision support features.
Package types
Analysis of intervention descriptions revealed that elec-
tronic prescribing packages varied according to whether
they were unmodified commercially available packages,
customised commercially available packages or bespoke
packages developed by staff in the hospitals in which
they were evaluated. Within these types, some packages
were designed specifically for use with children whilst
others employed generic adult-based systems. As illus-
trated in Table 2, four studies evaluated unmodified
commercially available or ‘off-the-shelf ’ packages, of
which only one was specifically designed for use with
children. Eight studies evaluated commercially available
packages that had been customised; in each case, custo-
misations involved making adult packages appropriate
for use in a paediatric setting. Six studies evaluated be-
spoke in-house developed systems; of which all but one
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were designed specifically for use with children. In two
papers, details of the package evaluated were so scant
that it was not possible to ascertain whether they were
customised or developed specifically for use with
children.
The thematic analysis of informal data on the experi-
ence of developing and implementing electronic pre-
scribing revealed a unanimous view among authors that
customisation for use with children is critical to the suc-
cess of interventions (see below). As Table 2 makes clear,
two of the three studies with negative findings evaluated
systems which were not tailored for use with children
specifically. Whilst the third study with negative findings
[42] evaluated a paediatric specific tool, it should be
noted that this study evaluated administration errors ra-
ther than prescribing errors. In essence, the study aimed
to examine through a simulated exercise the effect of
computerised orders, rather than handwritten ones, on
nurses ability to detect infusion pump programming er-
rors. As such, the decision support available, whilst
paediatric specific, was qualitatively different to decision
support for prescribing decisions as examined in other
studies.
Decision support—‘front-end’ and ‘back-end’ features
‘Front-end’ decision support features of the system [49]
are those that are actively accessed and manipulated by
the user to support decision-making such as dose calcu-
lators, structured order sets and access to other informa-
tion such as lab results or on-line formularies. System
features which were automatically triggered (as opposed
to intentionally accessed) were categorised as ‘back-end’
decision support features; they included alerts or warn-
ings about potentially harmful scenarios, mandatory
fields (preventing prescribers from continuing with or
submitting an order until all necessary fields were com-
pleted) or access security such as password entry. Table 2
illustrates which decision support features were de-
scribed in each study.
The inductive approach, which enabled the higher
level categorisation of decision support features, was val-
idated by patterns found in the assessment of informal






Front-end decision support Back-end decision support
Dose calculation Order sets Info access Alerts Mandatory fields Access security
Unmodified commercially available packages
Han et al. (2005) [31] USA ✓ ✓
Jani et al. (2010) [33] UK ✓ ✓ ✓
King (2003) [37] Canada ✓
Walsh (2008) [46] USA ✓ ✓ ✓ ✓ ✓
Customised commercially available packages
Cordero (2004) [28] USA ✓ ✓ ✓ ✓ ✓ ✓
Del Beccaro (2006) [30] USA ✓ ✓ ✓ ✓ ✓
Holdsworth (2007) [32] USA ✓ ✓ ✓ ✓ ✓ ✓
Kadmon (2009) [34] Israel ✓ ✓ ✓ ✓ ✓
Kazemi (2011) [35] Iran ✓ ✓ ✓ ✓ ✓ ✓
Keene (2007) [36] USA ✓ ✓ ✓ ✓
Upperman (2005) [44] USA ✓ ✓ ✓ ✓ ✓ ✓
Warrick (2011) [47] UK ✓ ✓ ✓ ✓
Bespoke packages (developed by trialists/hospitals)
Lehmann (2004) [38] USA ✓ ✓ ✓ ✓ ✓ ✓ ✓
Lehmann (2006) [39] USA ✓ ✓ ✓ ✓ ✓
Maat (2013) [40] Netherlands ✓ ✓ ✓ ✓
Potts (2004) [41] USA ✓ ✓ ✓
Sowan (2010) [42] USA ✓ ✓ ✓
Vardi (2007) [45] Israel ✓ ✓ ✓ ✓ ✓
Unidentified package type
Barnes (2009) [29] USA ✓ ✓
Sullins (2012) [43] USA
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data on strengths and weaknesses of intervention fea-
tures. We found that 15 studies commented on the value
of ‘front-end’ decision support and were unanimously of
the opinion that such features were a key factor in error
reduction. By contrast, just four authors commented on
the benefits of ‘back-end’ decision support suggesting its
relative lack of importance. As can be seen in Table 2,
both the Han et al. [31] and King et al. [37] studies had
far less sophisticated front-end decision support than
many of the other studies (as noted earlier, decision
support examined in the Sowan et al. study was not
comparable to that evaluated in other studies [42]).
Moreover, evidence also supported the relative lack of
importance of back-end decision support; despite result-
ing in increased mortality, the system evaluated in the
Han et al. study [31] appeared to have relatively compre-
hensive ‘back-end’ decision support.
These findings illustrate the value of combining the in-
ductive approach to assessment of intervention descrip-
tions with assessment of informal evidence to provide
insight into the strengths and weaknesses of specific
components of the intervention. The inductive deriv-
ation of features enabled categorisation of inconsistent
intervention descriptions and the representation of
studies in a tabular format. Alone, this visual juxtapos-
ition of study features would have been sufficient for
identification of associations between feature and out-
comes. However, the informal data on component
strengths and weaknesses provided further confirmatory
evidence regarding the validity of the identified
associations.
Developing and implementing electronic prescribing
The studies contained a wealth of informal data regard-
ing the development and implementation of electronic
prescribing programmes: five major themes about suc-
cessful practices emerged. The five themes are described
below and summarised in Table 3.
Customisation for use with children
A very common theme across the studies was the need
to customise generic electronic prescribing systems to
render them suitable for use with particular patient
groups: 14 studies recommended developing customised
electronic prescribing systems or warned against the use
of generic ‘off-the-peg’ tools [28, 30–36, 40, 41, 44–47].
Twelve studies specifically indicated the need for
paediatric-appropriate tools, for example, with decision
Table 3 Example evidence contributing to development and implementation themes




Informal evidence example Correspondence between themes and
study outcomes
1. Customisation for use with children 14 The risk of failing to customize existing
systems to assist with prescribing for
pediatric patients is likely substantial.
2 of the 3 studies with negative findings
were not customised for use with children.
The evaluation in the 3rd study was not
designed to test the impact of package
type on prescribing.(Holdsworth et al. 2007, p. 1064) [32]
2. Stakeholder engagement 9 Active involvement of our intensive care
staff during the design, build, and
implementation stages … are prerequisites
for a successful implementation.
None of the 3 studies with findings of harm
described a stakeholder engagement process.
(Del Beccaro et al. 2006, p. 294) [30]
3. Fostering familiarity 13 Probably the most important and
fundamental activity necessary for a smooth
transition to CPOE is staff CPOE training …
Poor training may lead to a lack of system
understanding, which can result in frustration,
poor acceptance, and a lack of full utilization.
The training provided in the Han et al. study
has been identified as inadequate, and no
training was described in the other 2 studies
with harmful outcomes. Studies measuring
at multiple time points show greater
benefits at later follow-up.
(Upperman et al. 2005a, p. e639) [44]
4. Adequate/appropriate
infrastructure
6 Our finding [of an increase in mortality]
may reflect a clinical applications program
implementation and systems integration
issue rather than a CPOE issue per se.
The Han et al. study acknowledges that
the harmful outcomes observed were likely
due to infrastructure problems rather than
EP itself.
(Han et al. 2005, p. 1511) [31]
5. Planning and iteration 14 It is important for hospitals to monitor,
continually modify, and improve CPOE
systems on the basis of data derived from
their own institution.
There was a relatively limited (3 months)
preparatory phase in the Han et al. study
in comparison to other studies.
(Walsh et al. 2008, p. e427) [46]
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support regarding age- and weight-based dosing, the
substantial changes in body proportions and compos-
ition that accompany growth and development mean
that doses of each medicine need to be calculated for
each child on an individual basis, rather than being
based on a standard dose as for adults. Indeed, three
studies emphasised that paediatric-customised systems
were an essential feature when using electronic prescrib-
ing for children [30, 32, 44]. As noted above, when com-
paring this theme against the findings of the effectiveness
synthesis, we found that two studies which found negative
findings [31, 37] evaluated off-the-peg commercially avail-
able packages not customised for use with children. In-
deed, Han and colleagues [31] acknowledged that the
harm caused by the electronic system they evaluated may
have been due, in part, to the use of a system designed for
adult settings.
Engaging with stakeholders during development
Nine studies described the involvement of stakeholders
in the development of ‘home-grown’ or ‘customised’
electronic prescribing systems; typically, the studies
emphasised the benefits of involving multidisciplinary
teams or a wide range of different stakeholders for en-
suring safety and enhancing relevance and utility. None
of the three studies in which harmful outcomes were
found described stakeholder engagement.
Fostering familiarity prior to implementation
Thirteen of the electronic prescribing studies advocated
enhancing familiarity with the electronic prescribing sys-
tem prior to the ‘go live’ stage. Studies suggested that
both acceptability and effectiveness could be detrimen-
tally affected by a lack of familiarity with electronic pre-
scribing systems. This finding was corroborated by the
findings of the effectiveness synthesis. The study by
Sowan and colleagues [42], which found negative im-
pacts on administration errors, was affected by this fac-
tor, noting that relative familiarity with established
systems, or perhaps even loyalty to existing systems, has
the potential to negate the benefits of a new system. In-
deed, Han and colleagues [31] explicitly acknowledged
that a lack of familiarity with the system may have con-
tributed to the increased number of deaths in their
study. Pre-implementation training delivered in the Han
et al. study was described as insufficient by authors of
another study who compared their approach to that of
Han and colleagues [36]; in the other two studies with
negative findings, no such training was described [37, 42].
The strongest evidence, however, came from two studies
that examined PME outcomes both immediately following
implementation and at later time periods; both found
greater benefits at the later time periods [38, 47].
Ensuring infrastructure is adequate and appropriate
Six studies commented on the issue of inadequate in-
frastructure for implementing electronic prescribing
[30, 31, 34, 38, 39, 44], for example, the accessibility
and availability of electronic prescribing points, the
capability of computer systems or the incompatibility
of the electronic prescribing system with existing pro-
cedures for speeding up the prescription process.
Again, Han and colleagues explicitly acknowledged
the potential for such infrastructure failures to have
contributed to the increased mortalities found in their
study: ‘Our finding may reflect a clinical applications pro-
gram implementation and systems integration issue rather
than a CPOE issue per se.’ [31] p. 1511].
Planning and iteration
Fourteen studies discussed implementation approaches
to support the development of appropriately customised
packages; all 14 recommended or implied the value of
an iterative approach whereby the electronic prescribing
system was customised post-implementation based on
user experience and identified needs. However, six of the
14 studies also recommended a long and careful pre-
implementation planning phase to pre-empt potential
problems. Two studies gave specific details of the length
of their pre-implementation preparatory phase, with one
study implying that preparation in the Han et al. study
was inadequate: ‘The preparatory phase took place dur-
ing approximately 2 yrs rather than the 3 months de-
scribed by Han and colleagues’ [36].
In sum, each of the inductively derived themes identi-
fied was corroborated in some way by evidence from the
effectiveness synthesis. Moreover, the validity of the ap-
proach and of employing informal evidence to develop
the themes is further underscored as each of the five im-
plementation themes also emerged in an independent
qualitative study of the views of UK practitioners on the
advantages and disadvantages of electronic prescribing
in paediatrics [50].
Discussion
Summary of key findings
ICA addresses a critical need for knowledge translation
to support policy decisions and evidence implementa-
tion. The formal and systematic approach for identifying
key intervention content and implementation processes
is designed to overcome the deficiencies of poor report-
ing which often hinders such work whilst also avoiding
the need to invest significant amounts of time and re-
sources in following up details with authors—with often
uncertain benefits. The inductive approach and analysis
of informal data are particularly useful for revealing po-
tentially overlooked aspects of interventions which are
actually important for their effectiveness, making it
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especially appropriate where hypothesised mechanisms
in an existing programme theory have failed. A further
benefit of the approach is its ability to identify poten-
tially new configurations of components that have not
yet been evaluated.
Strengths and limitations of ICA
Whilst ICA may be an effective method for the develop-
ment and articulation of hypotheses about critical inter-
vention features, effective approaches for testing such
hypotheses would also be desirable. The ICA approach
may be a useful precursor to formal analyses of variance
in outcomes, such as subgroup analyses and meta-
regression. Whilst these analyses may have limited bene-
fit in reviews such as the one in this example (as dis-
cussed in the Background section), ICA does offer a
formal process through which potentially explanatory
theories may be developed, which can then be tested for-
mally using standard statistical techniques.
Qualitative Comparative Analysis (QCA), an approach
which has recently been employed in systematic reviews
of complex interventions, is another method that may
be appropriate for testing the conclusions of an ICA
[51, 52]. QCA seeks to identify the necessary and suf-
ficient conditions for an outcome to be obtained and
is not subject to the limitations of the statistical
methods often used in meta-analysis; it works with
small numbers of studies but a large number of possible
factors that could explain variation in outcomes and can
cope with multiple pathways to success [51, 52].
QCA systematically identifies configurations, or com-
binations, of various interventions and other context-
ual characteristics that are (or are not) present when
the intervention has been successful (or not) in
obtaining a desired outcome and provides metrics for
assessing how consistent findings are. This quantifi-
cation of the link between intervention features and
outcomes would enhance the findings of ICA by pro-
viding a formal method to validate the generated the-
ories and enable us to move beyond the effective/not
effective dichotomy and (though the use of fuzzy
sets) rank studies according to the magnitude of
their effects. The approach we took is not dissimilar
to a ‘crisp set’ QCA without the formal testing for
coverage and consistency, which for the small num-
bers of studies we have in our example, are implicitly
assessed in terms of the identification of studies
which do not fit a given ‘solution’. Thus, since the
QCA method requires features for testing to be iden-
tified, the combination of ICA with QCA may be a
means to further propel the nascent utility of the
QCA method for examining complex interventions,
with QCA being particularly useful when the
magnitude of effect size estimates needs to be in-
cluded in the model.
An analysis driven by reviewer interpretation may be
susceptible to the biases that a priori specification of
data extraction categories in a typical subgroup analysis
seeks to prevent. However, its ability to reveal hidden or
neglected features, and barriers and facilitators only
identified in practical application, means that it is more
likely to avoid the pitfalls of simply providing a narrative
account describing individual interventions with no real
synthesis, which is often the result where there is too
much heterogeneity—and too little replication—for
meta-analysis to partition the variance successfully. The
key strengths of ICA are summarised in Table 4.
The validity of drawing on informal evidence
Mark Petticrew, in a previous issue of this journal, urged
systematic reviewers to ‘re-think’ some of the core prin-
ciples of systematic review practices in order to develop
appropriate evidence in answer to complex questions
and about complex interventions [53]. Thus, whilst we
recognise the potential dangers of drawing on informal
evidence, it could be considered equally imprudent to
dismiss outright this underutilised source of experiential
data. A wealth of valuable information is often presented
in the discussion sections of published reports, and the
question for the reviewer is how to understand the merit
and utility of this type of knowledge. It is not the out-
come of a formal piece of research or process evaluation,
certainly, and so cannot be regarded as being equivalent
to this form of knowledge. It does however reflect the
considered opinion of the authors, in the light of their
experiences in conducting their research. Can it there-
fore be regarded as being similar to the primary data
collected as the result of, e.g. interviews and question-
naires? In terms of sampling strategy, there is a clear
sampling frame, in that we have the views of a defined
set of authors. However, the data may not be as
complete as might be achievable through a separate
study which sought the views of these participants, as
not all may have felt the need to express ‘process’ opin-
ions, and different journals may have different attitudes
and requirements for the papers they accept. In addition,
the opportunities offered by the rich data available from
in-depth interviews clearly go beyond those offered in
short sections of a research report. Arguably, the views
Table 4 Overall strengths of ICA
• A streamlined approach for producing guidance to support
practical application of evidence about effective interventions
• Can uncover potentially neglected aspects of interventions which
are actually important for their effectiveness
• Potentially new configurations are identified, which may not
actually have been evaluated
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presented may also be biased, as they may be self-
justifying; however, the same weakness can affect data
collected through interviews as well, and moreover, these
data may actually be more reliable in some ways, as they
are the considered and distilled views of the authors, ra-
ther than their more instantaneous responses to an
interview question. The use of such evidence is perhaps
further justified by the lack of a viable alternative; there
is a critical need for information with regard to an un-
derstanding of the key ingredients of interventions and
also a lack of formal process evaluations. As Pawson and
colleagues recognise, ‘Information relating to …the subtle
contextual conditions that can make interventions float
or sink, will be much harder to come by … [reviewers]
need to draw judiciously upon a wide range of informa-
tion from diverse primary sources’ [18]. We therefore
regarded this potentially rich and largely ignored source
of trialists’ opinions as being a valuable, if potentially in-
complete, picture of their experiences with the interven-
tion, treated them as primary data and analysed them
accordingly, rather than as the product of robust re-
search for synthesis. We consider the approach to fit
with the spirit of evidence-based medicine ‘the conscien-
tious, explicit, and judicious use of current best evidence
in making decisions’ [54].
The applicability of the approach
One of the key strengths of ICA is that it works exclu-
sively with information contained within existing trial re-
ports, thereby avoiding the need for the significant
additional resources required for author survey or iden-
tification of qualitative research. However, despite the
acknowledged suboptimal descriptions of the electronic
prescribing packages in the synthesised trial reports,
some features of paediatric electronic prescribing may
have ensured that the nature of information contained
within the trial reports was particularly conducive to the
ICA approach. First, the inductive approach to coding
may have been particularly fruitful due to the newness
of electronic prescribing technology. In some ways the
newness of the technology can be seen as creating a
problem for identifying key intervention features, not
least because of inconsistencies in the terminology used.
This however, may have also been advantageous for the
ICA approach in this instance, since the lack of consen-
sus with regard to terminology meant that authors often
provided definition or description as well as naming fea-
tures. Whilst some intervention descriptions, particularly
in later reports, were scant, in other reports, the new-
ness of the technology may have been the reason for the
relatively detailed level of description; shorthand
descriptions are more likely where there is a well-
established intervention, and consensus about what it in-
volves, for example, lengthy descriptions of the features
of a parachute (e.g. ‘a folding, hemispherical fabric can-
opy with cords supporting a harness or straps for allow-
ing a person, object, package, etc., to float down safely
through the air from a great height’) are unlikely to be
considered necessary since this type of technology has
been in common usage for over a century [55]. More-
over, given that many of the interventions were devel-
oped in the hospitals in which they were employed and
evaluated and that many others were customised, trial-
ists may have been especially motivated to document
their developments and innovations with regard to this
technology, further enhancing the quality of description.
Nevertheless, whilst ICA may thus be less fruitful when
there is greater consensus about what an intervention
involves (and therefore less extensive description), it
must also be recognised that the main aim of the ap-
proach is to provide clarity in precisely those situations
where an intervention is not well established and there
is a lack of consensus about its critical features. A sec-
ond feature of paediatric electronic prescribing that may
have rendered it particularly suitable for ICA was that
an early study reported tragic adverse outcomes [30]. It
is clear that authors of subsequent trials felt compelled
to compare and contrast their findings with this particu-
lar trial [30, 32, 36] ensuring a wealth of accounts and
rich reflection on the critical differences between suc-
cessful and non-successful interventions; where less ex-
treme differences in outcomes are observed, it is
unlikely that reflection of this sort will occur. However,
since this is the first use of the ICA approach and the
first time that we are aware of systematic appraisal of
this type of informal information, the success of the en-
deavour in this instance suggests that ICA warrants fur-
ther application and testing.
The warrant of the knowledge generated
Whilst it is beyond the scope of this paper to discuss the
philosophy of science and evidence-informed decision-
making at length, a few observations may be helpful. We
have employed an explicitly inductive methodology,
which means that it is possible that some (or all) of our
findings are incorrect and that other factors may actually
be responsible for the differences between outcomes ob-
served. Given that most human knowledge is generated
inductively though, we do not think that this fact alone
should be the cause for rejecting this approach. Indeed,
the more traditional statistical subgroup analyses also
use induction, so it is clear, we think, that an inductive
approach is legitimate. Moreover, had we simply given a
narrative account of the studies and their findings, we
would have implicitly invited the reader to perform their
own informal inductive ICA, and we would argue that
our formal inductive analysis is far more systematic and
rigorous than any careful reading of intervention
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summaries might be, as we have systematically sought
for key characteristics of studies and their relationships
with observed outcomes. Indeed, this approach might
better be described as ‘abductive’ , ‘retroductive’ or an
‘inference to the best explanation’ form of induction,
where all factors, whether convenient (in terms of
producing a coherent explanation) or inconvenient,
are taken into consideration [56].
Whilst frequently criticised, the formal significance
test does provide some degree of protection against the
erroneous identification of a relationship between two
variables—where in fact, one may not exist; and an ICA
does not benefit from this protection (even where we
may have taken a difference in magnitude to be mean-
ingful of some real difference between interventions in
the ICA). Our response to this critique is threefold. First,
we need to acknowledge that this may be true—but we
have no way of knowing whether it is or it is not. Sec-
ond, we observe that we have taken far more ‘variables’
into account in this analysis than would be possible with
this small number of studies in a statistical analysis,
which actually may give us more confidence in the ro-
bustness of our findings. And third, that the warrant
gained through the use of inferential statistics—espe-
cially with small numbers of heterogeneous studies—-
may not be all that great, since we are unlikely to have a
random sample of all relevant studies. Indeed, we may
have all of the relevant studies (a census, where using in-
ferential statistics is obviously illogical), but even if this
is not the case, we do not have any evidence to assume
we have a genuine probability sample that would lend
support to inferences derived from statistical tests. The
use of standard statistical methods would have identified
significant heterogeneity between studies and, given the
fact that they differed in so many different ways, would
not have enabled us to go further than to say that we
could not explain it and that more research was needed.
In the words of Gene Glass, ‘classical statistics seems not
able to reproduce the complex cognitive processes that
are commonly applied with success by data analysts’ [57].
Conclusions
Information about the critical features of interventions
and guidance for their implementation are essential
components of systematic reviews if they are to be more
than an academic exercise and the widespread adoption
of evidence-based practice more than an aspiration.
Intervention Component Analysis is advanced as a
promising approach to build up a rich picture of those
intervention characteristics which may be associated
with successful (and unsuccessful) outcomes. Although
the pragmatic nature of ICA means that its findings
must be treated with care, it has a useful contribution to
make in utilising fully the available evidence.
Since it is the first use of such an approach that we are
aware of, there are naturally questions about its validity
and applicability. Further methodological work will be
essential for testing and refining the process as well as
for establishing optimal conditions for its use. Neverthe-
less, the urgent need to support decision-makers in
implementing review findings and the potential utility of
the approach as demonstrated within the worked ex-
ample merit such investigation.
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